TY - JOUR
T1 - Neuroprotective and preventative effects of molecular hydrogen
AU - Noda, Mami
AU - Liu, Jiankang
AU - Long, Jiangang
N1 - Funding Information:
This work was supported by the Grants-in-Aid for Scientific Research of Japan Society for Promotion of Science (JSPS 20K07133), the National Natural Science Foundation of China (No. 81741110, 31870848, 31570777 and 91649106), Natural Science Foundation of Shaanxi (No. 2018JZ3005), and the Fundamental Research Funds for the Central Universities (No. 08143008, 08143101).
Funding Information:
We thank Prof. David A. Brown (UCL, UK) for editing the manuscript and valuable comments. Original works were partially supported by the Research Support Center, Graduate School of Medical Sciences, Kyushu University.
Publisher Copyright:
© 2021 Bentham Science Publishers.
PY - 2021
Y1 - 2021
N2 - One of the beneficial effects of molecular hydrogen (H2, hydrogen gas) is neuroprotection and prevention of neurological disorders. It is important and useful if taking H2 every day can prevent or ameliorate the progression of neurodegenerative disorders, such as Parkinson’s disease or Alzheimer’s disease, both lacking specific therapeutic drugs. There are several mechanisms of how H2 protects neuronal damage. Anti-oxidative, anti-inflammatory, and the regulation of the endocrine system via stomach-brain connection seem to play an important role. At the cellular and tissue level, H2 appears to prevent the production of reactive oxygen species (ROS), and not only hydroxy radical (•OH) but also superoxide. In Parkinson’s disease model mice, chronic intake of H2 causes the release of ghrelin from the stomach. In Alzheimer’s disease model mice, sex-different neu-roprotection is observed by chronic intake of H2. In female mice, declines of estrogen and estrogen receptor-β (ERβ) are prevented by H2, upregulating brain-derived neurotrophic factor (BDNF) and its receptor, tyrosine kinase receptor B (TrkB). The question of how drinking H2 upregulates the release of ghrelin or attenuates the decline of estrogen remains to be investigated and the mechanism of how H2 modulates endocrine systems and the fundamental question of what or where is the target of H2 needs to be elucidated for a better understanding of the effects of H2.
AB - One of the beneficial effects of molecular hydrogen (H2, hydrogen gas) is neuroprotection and prevention of neurological disorders. It is important and useful if taking H2 every day can prevent or ameliorate the progression of neurodegenerative disorders, such as Parkinson’s disease or Alzheimer’s disease, both lacking specific therapeutic drugs. There are several mechanisms of how H2 protects neuronal damage. Anti-oxidative, anti-inflammatory, and the regulation of the endocrine system via stomach-brain connection seem to play an important role. At the cellular and tissue level, H2 appears to prevent the production of reactive oxygen species (ROS), and not only hydroxy radical (•OH) but also superoxide. In Parkinson’s disease model mice, chronic intake of H2 causes the release of ghrelin from the stomach. In Alzheimer’s disease model mice, sex-different neu-roprotection is observed by chronic intake of H2. In female mice, declines of estrogen and estrogen receptor-β (ERβ) are prevented by H2, upregulating brain-derived neurotrophic factor (BDNF) and its receptor, tyrosine kinase receptor B (TrkB). The question of how drinking H2 upregulates the release of ghrelin or attenuates the decline of estrogen remains to be investigated and the mechanism of how H2 modulates endocrine systems and the fundamental question of what or where is the target of H2 needs to be elucidated for a better understanding of the effects of H2.
UR - http://www.scopus.com/inward/record.url?scp=85102367916&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102367916&partnerID=8YFLogxK
U2 - 10.2174/1381612826666201019103020
DO - 10.2174/1381612826666201019103020
M3 - Short survey
C2 - 33076798
AN - SCOPUS:85102367916
SN - 1381-6128
VL - 27
SP - 585
EP - 591
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 5
ER -